semaglutide wearing off Semaglutide: Half of Users Stop Drug Within Year in 'Concerning' Drop Woman shares journey of weight

Employers cannot routinely access detailed medical records, and occupational health services must maintain confidentiality, sharing only fitness-for-work assessments with employers unless explicit consent is provided for additional disclosure

The limiting factor often isn't fitness

The treatment is generally less costly than prescription GLP-1 medication, making it an attractive option for patients on a budget

[37] Molecular genetic testing for growth hormone receptor gene mutations confirms the diagnosis of LS, but clinical evaluation may include laboratory analysis of basal GH, IGF-1 and IGFBP levels, GH stimulation testing, and/or GH trial therapy

Recent pharmacovigilance has also identified signals for intestinal obstruction (ileus) with some GLP-1 receptor agonists

You've landed at the right place